Stakeholders Warn Comparative Effectiveness Research Is No Magic Bullet
This article was originally published in The Gray Sheet
Executive Summary
As Congress moves closer to approving significant funding for comparative effectiveness programs, questions remain over how to structure a sustainable system for conducting the research and how to avoid unintended consequences in sharing the data
You may also be interested in...
Comparative Effectiveness Researchers Look Beyond Randomized Trials
Researchers awaiting guidance from the Administration on how it will allocate $1.1 billion in stimulus funds for comparative effectiveness research are exploring ways to include alternatives to randomized clinical trials in gathering evidence to inform health care decisions
Comparative Effectiveness Researchers Look Beyond Randomized Trials
Researchers awaiting guidance from the Administration on how it will allocate $1.1 billion in stimulus funds for comparative effectiveness research are exploring ways to include alternatives to randomized clinical trials in gathering evidence to inform health care decisions
CMS Coverage Director Steve Phurrough Will Move To AHRQ Outcomes Office
The Agency for Healthcare Research and Quality is already bolstering its capabilities in research on the comparative effectiveness of medical services with the addition of CMS official Steve Phurrough